T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JWN
1126
DELISTED
Nordstrom
JWN
| $18.8M | ﹤0.01% |
237,139
-146,145
| -38% | -$10.7M |
|
1127
Marriott Vacations Worldwide
VAC
$4.17B
| $18.8M | ﹤0.01% |
252,168
+79,900
| +46% | +$5.56M |
|
1128
SPX Corp
SPXC
$10.6B
| $18.8M | ﹤0.01% |
868,553
+804,981
| +1,266% | +$18M |
|
1129
CBRE Group
CBRE
$44B
| $18.7M | ﹤0.01% |
546,755
+36,410
| +7% | +$1.16M |
|
1130
FMC
FMC
$1.27B
| $18.6M | ﹤0.01% |
375,655
-25,113
| -6% | -$1.22M |
|
1131
Kopin
KOPN
$898M
| $18.6M | ﹤0.01% |
5,126,446
+347,520
| +7% | +$1.2M |
|
|
FNFV
1132
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $18.5M | ﹤0.01% |
1,540,436
-1,396,934
| -48% | -$15M |
|
|
AMAG
1133
DELISTED
AMAG Pharmaceuticals
AMAG
| $18.5M | ﹤0.01% |
432,970
+6,850
| +2% | +$248K |
|
1134
Avient
AVNT
$4.23B
| $18.4M | ﹤0.01% |
485,430
+126,400
| +35% | +$4.62M |
|
1135
iShares MSCI EAFE ETF
EFA
$80.3B
| $18.4M | ﹤0.01% |
301,861
+273,547
| +966% | +$17.1M |
|
|
MCF
1136
DELISTED
Contango Oil & Gas Co.
MCF
| $18.3M | ﹤0.01% |
626,281
-513,597
| -45% | -$17.3M |
|
1137
Copa Holdings
CPA
$6.17B
| $18.3M | ﹤0.01% |
176,160
+36,960
| +27% | +$3.93M |
|
|
AXE
1138
DELISTED
Anixter International Inc
AXE
| $18.2M | ﹤0.01% |
205,800
+5,100
| +3% | +$432K |
|
1139
Graphic Packaging
GPK
$3.51B
| $18.1M | ﹤0.01% |
1,330,113
+17,800
| +1% | +$221K |
|
|
LLL
1140
DELISTED
L3 Technologies, Inc.
LLL
| $18.1M | ﹤0.01% |
143,424
+95
| +0.1% | +$11.4K |
|
1141
Lindblad Expeditions
LIND
$2.26B
| $18.1M | ﹤0.01% |
1,799,970
+270
| +0% | +$2.62K |
|
1142
Manhattan Associates
MANH
$11.7B
| $18.1M | ﹤0.01% |
443,377
+12,534
| +3% | +$479K |
|
1143
Energy Recovery
ERII
$399M
| $18M | ﹤0.01% |
3,420,963
+12,900
| +0.4% | +$58.6K |
|
|
DYN
1144
DELISTED
Dynegy, Inc.
DYN
| $18M | ﹤0.01% |
593,960
-9,053,962
| -94% | -$279M |
|
|
BEL
1145
DELISTED
Belmond Ltd.
BEL
| $18M | ﹤0.01% |
1,454,830
-1,858,540
| -56% | -$21.2M |
|
|
CETV
1146
DELISTED
Central European Media Enterprises Ltd
CETV
| $18M | ﹤0.01% |
5,600,072
+11,300
| +0.2% | +$29K |
|
1147
Newell Brands
NWL
$2.63B
| $18M | ﹤0.01% |
471,367
| – | – |
|
1148
iShares MSCI India ETF
INDA
$6.58B
| $17.9M | ﹤0.01% |
+594,700
| New | +$18.3M |
|
1149
Oneok
OKE
$58.4B
| $17.9M | ﹤0.01% |
358,760
+25,600
| +8% | +$1.41M |
|
|
CJES
1150
DELISTED
C&J ENERGY SVCS LTD
CJES
| $17.8M | ﹤0.01% |
1,350,100
-211,800
| -14% | -$3.78M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.